John P. Bader

4.4k total citations · 1 hit paper
85 papers, 3.7k citations indexed

About

John P. Bader is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, John P. Bader has authored 85 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 28 papers in Genetics and 27 papers in Infectious Diseases. Recurrent topics in John P. Bader's work include Virus-based gene therapy research (28 papers), Animal Virus Infections Studies (25 papers) and HIV Research and Treatment (22 papers). John P. Bader is often cited by papers focused on Virus-based gene therapy research (28 papers), Animal Virus Infections Studies (25 papers) and HIV Research and Treatment (22 papers). John P. Bader collaborates with scholars based in United States, Malaysia and Ukraine. John P. Bader's co-authors include O. S. Weislow, Michael R. Boyd, Rebecca Kiser, Robert H. Shoemaker, Donald L. Fine, Theodore L. Steck, Yozo Nakata, Robert W. Buckheit, William G. Rice and A. Walan and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John P. Bader

84 papers receiving 3.3k citations

Hit Papers

New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: ... 1989 2026 2001 2013 1989 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity
    1989 615 citations O. S. Weislow, Rebecca Kiser et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Bader United States 33 1.6k 1.1k 873 614 512 85 3.7k
John Kay United Kingdom 38 2.1k 1.4× 1.3k 1.2× 1.2k 1.4× 175 0.3× 349 0.7× 143 5.1k
Donald L. Fine United States 19 1.9k 1.2× 500 0.5× 370 0.4× 488 0.8× 381 0.7× 52 4.5k
Amnon Hizi Israel 42 2.8k 1.8× 2.8k 2.6× 2.9k 3.3× 449 0.7× 665 1.3× 143 5.6k
K.E. Ebner United States 34 2.1k 1.4× 363 0.3× 187 0.2× 862 1.4× 162 0.3× 113 4.2k
Henri Vial France 41 1.8k 1.2× 540 0.5× 285 0.3× 199 0.3× 1.1k 2.2× 175 5.6k
József Tőzsér Hungary 38 2.5k 1.6× 1.4k 1.2× 1.2k 1.4× 340 0.6× 329 0.6× 160 5.2k
Nancy M. Dunlop United States 32 2.4k 1.5× 835 0.8× 2.0k 2.2× 402 0.7× 618 1.2× 52 5.5k
P.A. Walker United Kingdom 36 4.7k 3.0× 673 0.6× 560 0.6× 505 0.8× 2.3k 4.4× 50 7.3k
Richard L. Tolman United States 30 1.5k 1.0× 478 0.4× 167 0.2× 297 0.5× 910 1.8× 103 3.3k
Marie-Pierre Egloff France 16 1.5k 0.9× 1.0k 0.9× 341 0.4× 127 0.2× 136 0.3× 20 3.2k

Countries citing papers authored by John P. Bader

Since Specialization
Citations

This map shows the geographic impact of John P. Bader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Bader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Bader more than expected).

Fields of papers citing papers by John P. Bader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Bader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Bader. The network helps show where John P. Bader may publish in the future.

Co-authorship network of co-authors of John P. Bader

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Bader. A scholar is included among the top collaborators of John P. Bader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Bader. John P. Bader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buckheit, Robert W., Sherman F. Stinson, Valerie Fliakas-Boltz, et al.. (1997). Efficacy, Pharmacokinetics, and in Vivo Antiviral Activity of UC781, a Highly Potent, Orally Bioavailable Nonnucleoside Reverse Transcriptase Inhibitor of HIV Type 1. AIDS Research and Human Retroviruses. 13(9). 789–796. 25 indexed citations
2.
Domagala, John M., John P. Bader, Rocco D. Gogliotti, et al.. (1997). A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: The 2,2′-dithiobisbenzamides. Bioorganic & Medicinal Chemistry. 5(3). 569–579. 33 indexed citations
3.
Rice, William G., Jim A. Turpin, Mingjun Huang, et al.. (1997). Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nature Medicine. 3(3). 341–345. 83 indexed citations
4.
Lackman-Smith, Carol, John P. Bader, William G. Rice, et al.. (1996). Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene. Antiviral Research. 33(1). 41–53. 14 indexed citations
5.
Clanton, David J., R W Buckheit, Rebecca Kiser, et al.. (1995). Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV. Antiviral Research. 27(4). 335–354. 41 indexed citations
6.
Buckheit, Robert W., Valerie Fliakas-Boltz, O. S. Weislow, et al.. (1995). Resistance to 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine Derivatives Is Generated by Mutations at Multiple Sites in the HIV-1 Reverse Transcriptase. Virology. 210(1). 186–193. 37 indexed citations
7.
Rice, William G. & John P. Bader. (1995). Discovery and in Vitro Development of AIDS Antiviral Drugs as Biopharmaceuticals. Advances in pharmacology. 33. 389–438. 25 indexed citations
8.
Cushman, Mark, W. Marek Gołębiewski, James B. McMahon, et al.. (1994). Design, Synthesis, and Biological Evaluation of Cosalane, a Novel Anti-HIV Agent Which Inhibits Multiple Features of Virus Reproduction. Journal of Medicinal Chemistry. 37(19). 3040–3050. 48 indexed citations
9.
Buckheit, Robert W., Valerie Fliakas-Boltz, W. Don Decker, et al.. (1994). Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors. Antiviral Research. 25(1). 43–56. 102 indexed citations
10.
Buckheit, Robert W., Melinda G. Hollingshead, E. Lucile White, et al.. (1993). Thiazolobenzimidazole: Biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. Antiviral Research. 21(3). 247–265. 86 indexed citations
11.
Walan, A., John P. Bader, M. Claßen, et al.. (1989). Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer. New England Journal of Medicine. 320(2). 69–75. 294 indexed citations
12.
Bader, John P. & David A. Ray. (1976). Configurational variants of oncornavirus RNAs. Journal of Virology. 19(3). 810–819. 6 indexed citations
13.
Bader, John P., et al.. (1976). Uptake of exogenous metabolites by virus-transformed cells: Changes induced by temperature and pH. Archives of Biochemistry and Biophysics. 175(1). 196–208. 9 indexed citations
14.
Bader, John P.. (1973). Virus-Induced Transformation without Cell Division. Science. 180(4090). 1069–1071. 11 indexed citations
15.
Bader, John P. & H. R. Morgan. (1961). LATENT VIRAL INFECTION OF CELLS IN TISSUE CULTURE. The Journal of Experimental Medicine. 113(2). 271–281. 11 indexed citations
16.
Bader, John P. & H. R. Morgan. (1961). A Comparison of Cytopathology Caused by Myxoviruses. The Journal of Immunology. 87(1). 80–89. 3 indexed citations
17.
Bader, John P. & H. R. Morgan. (1961). A Comparison of Cytopathology Caused by Myxoviruses. The Journal of Immunology. 87(1). 90–95. 1 indexed citations
18.
Bader, John P. & H. R. Morgan. (1961). Latent Viral Infection of Cells in Tissue Culture. IX. Abortive Infection with Psittacosis Virus.. Experimental Biology and Medicine. 106(2). 311–313. 2 indexed citations
19.
Bader, John P. & H. R. Morgan. (1958). LATENT VIRAL INFECTION OF CELLS IN TISSUE CULTURE. The Journal of Experimental Medicine. 108(5). 617–630. 25 indexed citations
20.
Maroteaux, P, et al.. (1957). ÉTUDE GÉNÉTIQUE DU GARGOYLISME. Human Heredity. 7(1). 113–114. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Kay Breakdown of academic impact, for papers by Donald L. Fine Breakdown of academic impact, for papers by Amnon Hizi Breakdown of academic impact, for papers by K.E. Ebner Breakdown of academic impact, for papers by Henri Vial Breakdown of academic impact, for papers by József Tőzsér Breakdown of academic impact, for papers by Nancy M. Dunlop Breakdown of academic impact, for papers by P.A. Walker Breakdown of academic impact, for papers by Richard L. Tolman Breakdown of academic impact, for papers by Marie-Pierre Egloff
Rankless by CCL
2026